Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 2Urologic Diseases 1Pancreatic Neoplasms 1Nephritis 1Neoplasms 1Melanoma 1Mastocytosis 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Kidney Diseases 1Immune System Diseases 1Hypoxia 1Glomerulonephritis, IGA 1Glomerulonephritis 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Autoimmune Diseases 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Imatinib Mesylate 4Hydroxyurea 4Cytarabine 4Antilymphocyte Serum 4Radiotherapy 3Melphalan 3Interferon-alpha 3Dasatinib 3olverembatinib 2Tacrolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Idarubicin 2Filgrastim 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2sargramostim 1nilotinib 1inecalcitol 1flumatinib 1danusertib 1avelumab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid, Chronic-Phase × Hydroxychloroquine × Clear all
NCT01227135 2011-11-30

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

University of Glasgow

Phase 2 Unknown
66 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡